Level Biotechnology Inc. (TPEX:3118)
Taiwan · Delayed Price · Currency is TWD 31.55
+0.30 (0.96%)
Jun 18, 2026, 1:30 PM CST
Level Biotechnology Market Cap
Level Biotechnology has a market cap or net worth of 1.02 billion as of June 18, 2026. Its market cap has decreased by -6.52% in one year.
Market Cap
1.02B
Enterprise Value
808.52M
Revenue
718.58M
Ranking
n/a
PE Ratio
13.37
Stock Price
31.55
Market Cap Chart
Since November 3, 2004, Level Biotechnology's market cap has increased from 249.68M to 1.02B, an increase of 310.08%. That is a compound annual growth rate of 6.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.02B | -4.39% |
| Dec 31, 2025 | 1.07B | 3.13% |
| Dec 31, 2024 | 1.04B | 5.09% |
| Dec 29, 2023 | 988.19M | 10.13% |
| Dec 30, 2022 | 897.32M | -7.68% |
| Dec 30, 2021 | 971.96M | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enimmune | 1.21B |
| BiOptic | 1.13B |
| LabTurbo Biotech | 1.09B |
| Holy Stone Healthcare | 1.07B |
| Lukas Biomedical | 1.03B |
| GeneReach Biotechnology | 999.94M |
| U-Neuron Biomedical | 960.38M |
| Meribank Biotech | 954.00M |